InvestorsHub Logo
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

Re: gpo344 post# 4319

Wednesday, 12/22/2010 7:58:32 PM

Wednesday, December 22, 2010 7:58:32 PM

Post# of 80490

but Gleevac is still very effective, and so are the others.


None of the currently approved drugs are effective against the T315I mutation and in CP pts who have failed at least 2 TKI's, Ponatinib has shown response rates equal to or exceeding any of the currently approved therapies.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.